开云app官网登录入口网页版-官方正版

#FAS#

132篇内容 | 2508人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2201001, encodeId=f5cb22010014d, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a> <a href='/topic/show?id=1460113954f7' target=_blank style='color:#2F92EE;'>#外国口音综合症#</a>, objectTitle=外语速成？土生土长的英国老人中风恢复后，竟突然“会说俄语”了？甚至还“会德语”？, objectType=article, longId=823708, objectId=501d823e0845, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=501d823e0845, replyNumber=0, likeNumber=71, createdTime=2024-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=501d823e0845, moduleTitle=外语速成？土生土长的英国老人中风恢复后，竟突然“会说俄语”了？甚至还“会德语”？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=501d823e0845)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2058003, encodeId=47e3205800379, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FDA要求阿斯利康（AstraZeneca）提供更多关于的Fasenra治疗慢性鼻窦炎伴鼻息肉的数据, objectType=article, longId=300798, objectId=f582300e985d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f582300e985d, replyNumber=0, likeNumber=118, createdTime=2023-02-15, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f582300e985d, moduleTitle=FDA要求阿斯利康（AstraZeneca）提供更多关于的Fasenra治疗慢性鼻窦炎伴鼻息肉的数据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f582300e985d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2058004, encodeId=f204205800484, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=远离不粘锅和化妆品！PFAS一旦入体，无法排出，持续产生永久化学伤害！, objectType=article, longId=737570, objectId=5278e37570d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5278e37570d6, replyNumber=0, likeNumber=89, createdTime=2022-11-08, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5278e37570d6, moduleTitle=远离不粘锅和化妆品！PFAS一旦入体，无法排出，持续产生永久化学伤害！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5278e37570d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2058001, encodeId=e61920580014c, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, objectType=article, longId=218722, objectId=0a93218e222e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a93218e222e, replyNumber=0, likeNumber=84, createdTime=2022-02-26, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a93218e222e, moduleTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a93218e222e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2058000, encodeId=d97d205800098, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, objectType=article, longId=215987, objectId=73ce21598e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ce21598e81, replyNumber=0, likeNumber=95, createdTime=2022-04-11, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ce21598e81, moduleTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=73ce21598e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2058002, encodeId=30fe205800207, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FDA授予IL-5抑制剂Fasenra（贝那利珠单抗）快速通道资格，用于治疗嗜酸性粒细胞性胃炎（EG）, objectType=article, longId=220145, objectId=3588220145b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3588220145b0, replyNumber=0, likeNumber=81, createdTime=2021-12-24, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3588220145b0, moduleTitle=FDA授予IL-5抑制剂Fasenra（贝那利珠单抗）快速通道资格，用于治疗嗜酸性粒细胞性胃炎（EG）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3588220145b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057997, encodeId=6f7f205e997e4, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, objectType=article, longId=202761, objectId=152c202e61d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c202e61d8, replyNumber=0, likeNumber=96, createdTime=2021-10-01, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c202e61d8, moduleTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=152c202e61d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057992, encodeId=42a5205e9924f, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效, objectType=article, longId=195473, objectId=16a61954e3e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a61954e3e1, replyNumber=0, likeNumber=90, createdTime=2021-04-04, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a61954e3e1, moduleTitle=Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=16a61954e3e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057995, encodeId=4f13205e995c9, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=阿斯利康的IL-5受体单抗Fasenra：III期临床证实在嗜酸性哮喘中具有强大疗效, objectType=article, longId=198911, objectId=81e1198911ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81e1198911ce, replyNumber=0, likeNumber=73, createdTime=2021-01-01, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81e1198911ce, moduleTitle=阿斯利康的IL-5受体单抗Fasenra：III期临床证实在嗜酸性哮喘中具有强大疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=81e1198911ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057989, encodeId=42bb205e989f4, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=e-FAST快速诊断法指导麻醉术中重症休克抢救成功一例, objectType=article, longId=194457, objectId=fa1319445e3a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1319445e3a, replyNumber=0, likeNumber=73, createdTime=2020-11-12, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1319445e3a, moduleTitle=e-FAST快速诊断法指导麻醉术中重症休克抢救成功一例, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fa1319445e3a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057999, encodeId=7e46205e9991d, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=Environ Sci Pollut Res Int：FAS基因的多态性与噪声引起的听力损失易感性有关 , objectType=article, longId=206468, objectId=eafc2064683d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eafc2064683d, replyNumber=0, likeNumber=91, createdTime=2021-07-19, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eafc2064683d, moduleTitle=Environ Sci Pollut Res Int：FAS基因的多态性与噪声引起的听力损失易感性有关 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eafc2064683d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057988, encodeId=e336205e9888a, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=CAR-T对手来了！CD19单抗tafasitamab联合来那度胺治疗淋巴瘤提交FDA上市申请, objectType=article, longId=193578, objectId=2e2f1935e8e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e2f1935e8e9, replyNumber=0, likeNumber=99, createdTime=2021-03-25, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e2f1935e8e9, moduleTitle=CAR-T对手来了！CD19单抗tafasitamab联合来那度胺治疗淋巴瘤提交FDA上市申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2e2f1935e8e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057998, encodeId=de81205e9983a, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FASEB J：牙周细菌竟可通过肠道微生物组导致代谢综合征？, objectType=article, longId=204482, objectId=d4f9204482d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4f9204482d7, replyNumber=0, likeNumber=89, createdTime=2021-11-11, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4f9204482d7, moduleTitle=FASEB J：牙周细菌竟可通过肠道微生物组导致代谢综合征？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d4f9204482d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057990, encodeId=edd6205e99016, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=EMA开始审查MorphoSys的CD19单抗tafasitamab，治疗淋巴瘤, objectType=article, longId=194616, objectId=2a611946163b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a611946163b, replyNumber=0, likeNumber=81, createdTime=2020-08-29, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a611946163b, moduleTitle=EMA开始审查MorphoSys的CD19单抗tafasitamab，治疗淋巴瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2a611946163b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057991, encodeId=9247205e99109, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=Cell Death & Disease：抗雌激素药物Faslodex能够增加RCC患者对Sunitinib的敏感性, objectType=article, longId=195178, objectId=e7211951e8de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7211951e8de, replyNumber=0, likeNumber=77, createdTime=2021-03-13, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7211951e8de, moduleTitle=Cell Death & Disease：抗雌激素药物Faslodex能够增加RCC患者对Sunitinib的敏感性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e7211951e8de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057996, encodeId=1af9205e996e8, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FASEB J：研究发现，蓝莓中的这种多酚类化合物可改善结肠炎症, objectType=article, longId=201716, objectId=624b201e16bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=624b201e16bc, replyNumber=0, likeNumber=95, createdTime=2021-03-16, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=624b201e16bc, moduleTitle=FASEB J：研究发现，蓝莓中的这种多酚类化合物可改善结肠炎症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=624b201e16bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057984, encodeId=36cc205e984ec, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=亘喜生物公布FasTCAR 和Dual CAR 细胞平台技术在多个人体临床试验中得到的新近进展, objectType=article, longId=184650, objectId=0b4c18465050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b4c18465050, replyNumber=0, likeNumber=72, createdTime=2020-11-13, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b4c18465050, moduleTitle=亘喜生物公布FasTCAR 和Dual CAR 细胞平台技术在多个人体临床试验中得到的新近进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0b4c18465050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057993, encodeId=a30e205e99381, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=Sci Adv：华东师大叶海峰团队：研发出一种远红光激活的基因编辑系统——FAST, objectType=article, longId=197548, objectId=453f19e54812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=453f19e54812, replyNumber=0, likeNumber=81, createdTime=2020-07-17, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=453f19e54812, moduleTitle=Sci Adv：华东师大叶海峰团队：研发出一种远红光激活的基因编辑系统——FAST, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=453f19e54812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057994, encodeId=6af6205e99483, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤, objectType=article, longId=198654, objectId=e12d1986548a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12d1986548a, replyNumber=0, likeNumber=66, createdTime=2020-12-19, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12d1986548a, moduleTitle=FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e12d1986548a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057983, encodeId=90fc205e98360, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, objectTitle=FDA批准预填充自动注射器Fasenra治疗哮喘, objectType=article, longId=180546, objectId=25eb180546e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25eb180546e0, replyNumber=0, likeNumber=89, createdTime=2020-09-03, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25eb180546e0, moduleTitle=FDA批准预填充自动注射器Fasenra治疗哮喘, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=25eb180546e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

FAS

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#FAS# #外国口音综合症#

外语速成？土生土长的英国老人中风恢复后，竟突然“会说俄语”了？甚至还“会德语”？

2024-04-29发表于陕西省

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FDA要求阿斯利康（AstraZeneca）提供更多关于的Fasenra治疗慢性鼻窦炎伴鼻息肉的数据

2023-02-15

gracezdd (审核中...)

前往app查看评论内容

#FAS#

远离不粘锅和化妆品！PFAS一旦入体，无法排出，持续产生永久化学伤害！

2022-11-08

gracezdd (审核中...)

前往app查看评论内容

#FAS#

Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局

2022-02-26

gracezdd (审核中...)

前往app查看评论内容

#FAS#

JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病

2022-04-11

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FDA授予IL-5抑制剂Fasenra（贝那利珠单抗）快速通道资格，用于治疗嗜酸性粒细胞性胃炎（EG）

2021-12-24

gracezdd (审核中...)

前往app查看评论内容

#FAS#

哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素

2021-10-01

gracezdd (审核中...)

前往app查看评论内容

#FAS#

Lancet oncol：Tafasitamab联合来那度胺治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效

2021-04-04

gracezdd (审核中...)

前往app查看评论内容

#FAS#

阿斯利康的IL-5受体单抗Fasenra：III期临床证实在嗜酸性哮喘中具有强大疗效

2021-01-01

gracezdd (审核中...)

前往app查看评论内容

#FAS#

e-FAST快速诊断法指导麻醉术中重症休克抢救成功一例

2020-11-12

gracezdd (审核中...)

前往app查看评论内容

#FAS#

Environ Sci Pollut Res Int：FAS基因的多态性与噪声引起的听力损失易感性有关

2021-07-19

gracezdd (审核中...)

前往app查看评论内容

#FAS#

CAR-T对手来了！CD19单抗tafasitamab联合来那度胺治疗淋巴瘤提交FDA上市申请

2021-03-25

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FASEB J：牙周细菌竟可通过肠道微生物组导致代谢综合征？

2021-11-11

gracezdd (审核中...)

前往app查看评论内容

#FAS#

EMA开始审查MorphoSys的CD19单抗tafasitamab，治疗淋巴瘤

2020-08-29

gracezdd (审核中...)

前往app查看评论内容

#FAS#

Cell Death & Disease：抗雌激素药物Faslodex能够增加RCC患者对Sunitinib的敏感性

2021-03-13

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FASEB J：研究发现，蓝莓中的这种多酚类化合物可改善结肠炎症

2021-03-16

gracezdd (审核中...)

前往app查看评论内容

#FAS#

亘喜生物公布FasTCAR 和Dual CAR 细胞平台技术在多个人体临床试验中得到的新近进展

2020-11-13

gracezdd (审核中...)

前往app查看评论内容

#FAS#

Sci Adv：华东师大叶海峰团队：研发出一种远红光激活的基因编辑系统——FAST

2020-07-17

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FDA批准Monjuvi（tafasitamab-cxix）联合来那度胺治疗复发难治弥漫性大B细胞淋巴瘤

2020-12-19

gracezdd (审核中...)

前往app查看评论内容

#FAS#

FDA批准预填充自动注射器Fasenra治疗哮喘

2020-09-03

科室
- - 订阅+
  - 更多科室
工具
服务